Review
Published on 20 Oct 2023
Ferroptosis: the emerging player in remodeling triple-negative breast cancer
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2023.1284057
- 11,005 views
- 43 citations
Type at least 3 characters
4,884 articles
Review
Published on 20 Oct 2023
Novel insights into IL-37: an anti-inflammatory cytokine with emerging roles in anti-cancer process
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2023.1278521
- 8,622 views
- 14 citations
Original Research
Published on 20 Oct 2023
Multi-omics analysis reveals interferon-stimulated gene OAS1 as a prognostic and immunological biomarker in pan-cancer
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2023.1249731
- 7,974 views
- 12 citations
Brief Research Report
Published on 20 Oct 2023
Preclinical study of CD19 detection methods post tafasitamab treatment
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2023.1274556
- 5,884 views
- 4 citations
Review
Published on 20 Oct 2023
γδ T cells as a potential therapeutic agent for glioblastoma
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2023.1273986
- 7,297 views
- 12 citations
Original Research
Published on 20 Oct 2023
Xenogeneic equine stem cells activate anti-tumor adaptive immunity in a 4T1-based intraductal mouse model for triple-negative breast cancer: proof-of-principle
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2023.1252374
- 3,264 views
- 1 citation
Original Research
Published on 20 Oct 2023
Selective reprogramming of regulatory T cells in solid tumors can strongly enhance or inhibit tumor growth
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2023.1274199
- 4,188 views
- 3 citations
Review
Published on 20 Oct 2023
Targeting the dendritic cell-T cell axis to develop effective immunotherapies for glioblastoma
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2023.1261257
- 6,570 views
- 14 citations
Review
Published on 19 Oct 2023
Combinatorial blockade for cancer immunotherapy: targeting emerging immune checkpoint receptors
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2023.1264327
- 7,178 views
- 33 citations
Original Research
Published on 19 Oct 2023
IGFBP2 from a novel copper metabolism-associated biomarker promoted glioma progression and response to immunotherapy
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2023.1282734
- 4,651 views
- 5 citations
Original Research
Published on 19 Oct 2023
Features of the TCR repertoire associate with patients' clinical and molecular characteristics in acute myeloid leukemia
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2023.1236514
- 6,044 views
- 3 citations
Original Research
Published on 19 Oct 2023
Computational identification and clinical validation of a novel risk signature based on coagulation-related lncRNAs for predicting prognosis, immunotherapy response, and chemosensitivity in colorectal cancer patients
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2023.1279789
- 4,989 views
- 2 citations
Original Research
Published on 19 Oct 2023
Portal vein tumour thrombosis radiotherapy improves the treatment outcomes of immunotherapy plus bevacizumab in hepatocellular carcinoma: a multicentre real-world analysis with propensity score matching
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2023.1254158
- 4,978 views
- 6 citations
Original Research
Published on 19 Oct 2023
13C tracer analysis reveals the landscape of metabolic checkpoints in human CD8+ T cell differentiation and exhaustion
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2023.1267816
- 10,217 views
- 6 citations
Original Research
Published on 18 Oct 2023
NKG2D-CAR memory T cells target pediatric T-cell acute lymphoblastic leukemia in vitro and in vivo but fail to eliminate leukemia initiating cells
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2023.1187665
- 6,455 views
- 11 citations
Case Report
Published on 18 Oct 2023
Case Report: Successful conversion and salvage resection of huge hepatocellular carcinoma with portal vein tumor thrombosis and intrahepatic metastasis via sequential hepatic arterial infusion chemotherapy, lenvatinib plus PD-1 antibody followed by simultaneous transcatheter arterial chemoembolization, and portal vein embolization
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2023.1285296
- 6,232 views
- 8 citations